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The scaffold protein PSD-95 promotes the
maturation and strengthening of excitatory syn-
apses, functions that require proper localization
of PSD-95 in the postsynaptic density (PSD).
Here we report that phosphorylation of ser-295
enhances the synaptic accumulation of PSD-
95 and the ability of PSD-95 to recruit surface
AMPA receptors andpotentiate excitatorypost-
synaptic currents. We present evidence that
a Rac1-JNK1 signaling pathway mediates ser-
295 phosphorylation and regulates synaptic
content of PSD-95. Ser-295 phosphorylation is
suppressed by chronic elevation, and increased
by chronic silencing, of synaptic activity. Rapid
dephosphorylation of ser-295 occurs in re-
sponse to NMDA treatment that causes chemi-
cal long-termdepression (LTD).Overexpression
of a phosphomimicking mutant (S295D) of
PSD-95 inhibited NMDA-induced AMPA recep-
tor internalization and blocked the induction of
LTD. The data suggest that synaptic strength
can be regulated by phosphorylation-dephos-
phorylation of ser-295 of PSD-95 and that syn-
aptic depression requires the dephosphoryla-
tion of ser-295.
INTRODUCTION
PSD-95 is an important scaffold protein abundantly en-
riched in the PSD of excitatory synapses (Cheng et al.,
2006; Kim and Sheng, 2004). PSD-95 contains three PDZ
domains, an SH3 domain, and a guanylate kinase-like do-
main. The PDZ domains in particular mediate a wealth of
interactions with intracellular signaling molecules and
cell-surface adhesionmolecules, ion channels, and recep-
tors, including NMDA receptors (Kim and Sheng, 2004;
Scannevin and Huganir, 2000).488 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc.PSD-95 promotes synapse maturation and exerts a
major influence on synaptic strength and plasticity (El-
Husseini et al., 2000; Elias et al., 2006). Overexpression
of PSD-95 strongly potentiates AMPAR-mediated excit-
atory postsynaptic currents (EPSCs) (Beique and An-
drade, 2003; Ehrlich and Malinow, 2004; El-Husseini
et al., 2000; Elias et al., 2006; Futai et al., 2007; Nakagawa
et al., 2004; Stein et al., 2003). Synaptic potentiation in-
duced by the overexpression of PSD-95 shares some fea-
tures with long-term potentiation (LTP), in that it converts
silent synapses into functional synapses, drives GluR1
into synapses, and occludes LTP (Beique and Andrade,
2003; Ehrlich and Malinow, 2004; Stein et al., 2003). How-
ever, it is uncertain if LTP actually results from activity-
induced recruitment of PSD-95 to synapses.
The synaptic targeting of PSD-95 depends on several
domains within the protein (Craven et al., 1999). Palmitoy-
lation of two cysteine residues in its N-terminal region is
important for synaptic localization of PSD-95 and for syn-
aptic potentiation by PSD-95 (Craven et al., 1999; El-Hus-
seini et al., 2002). The level of PSD-95 palmitoylation is
regulated by synaptic activity, and inhibition of palmitoyla-
tion is associated with loss of PSD-95 from synapses (El-
Husseini et al., 2002). Because synaptic localization is es-
sential for PSD-95’s potent ability to promote synaptic
strength, any molecular mechanism that affects the syn-
aptic targeting or synaptic stability of PSD-95 could play
an important role in the control of postsynaptic maturation
and synaptic transmission.
Compared with palmitoylation (El-Husseini et al., 2002)
and ubiquitination (Colledge et al., 2003) (but see Bingol
and Schuman, 2004), surprisingly little is known about
the regulation of PSD-95 by phosphorylation. Recent pro-
teomic studies of phosphorylated proteins of the PSD
fraction revealed that PSD-95 is phosphorylated on ser-
ine-295 (Jaffe et al., 2004; Trinidad et al., 2006), a residue
lying between PDZ2 and PDZ3 of PSD-95. Here, we inves-
tigated the functional significance and molecular regula-
tionof this phosphorylation. The phosphorylation of ser-295,
which is bidirectionally modulated by synaptic activity in
neurons, promotes the synaptic accumulation of PSD-95
and enhances synaptic potentiation by PSD-95. We
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PSD-95 Phosphorylation by Rac-JNKpresent evidence that ser-295 phosphorylation is medi-
ated by Jun N-terminal kinase1 (JNK1) and dependent
on Rac1, and that dephosphorylation of ser-295 is impor-
tant for inducible AMPA receptor internalization and LTD.
These results reveal a role for phosphorylation-dephos-
phorylation of a specific residue of PSD-95 in the control
of synaptic function.
RESULTS
Phosphorylation of Ser-295 Promotes Synaptic
Accumulation of PSD-95
PSD-95 is phosphorylated in the brain on ser-295, which
lies in the sequence RRYSPVAK (Jaffe et al., 2004; Trini-
dad et al., 2006). We presume that this site is phosphory-
lated by a proline-directed kinase, such as a MAP kinase
or CDK5.
To investigate the functional significance of PSD-95 ser-
295 phosphorylation, we made mutants S295D-PSD-95
(to mimic ser-295 phosphorylation) and S295A-PSD-95
(to prevent ser-295 phosphorylation) and examined their
subcellular localization in cultured hippocampal neurons.
The level of protein expression of these mutant constructs
was statistically the same as wild-type PSD-95 when
transfected in neurons (Figure S1) and in heterologous cells
(data not shown). Wild-type PSD-95 and S295D-PSD-95
showed a punctate pattern of staining along dendrites of
transfected neurons, with a high degree of colocalization
with surface GluR1 clusters and bassoon clusters (Figures
1A–1C). In contrast, the S295A-PSD-95 mutant showed
considerable diffuse staining in the dendritic shaft in addi-
tion to high expression in spines (Figures 1A–1C). Thus, the
S295A mutant concentrates at synapses less efficiently
than wild-type or phosphomimic mutant of PSD-95.
The synaptic targeting of PSD-95 is essential for its abil-
ity to promote the surface expression of GluR1 AMPA
receptors and to enhance the intensity of bassoon staining
in presynaptic terminals that contact the transfected neu-
ron (El-Husseini et al., 2000). By immunostaining, we
found that S295D-PSD-95 and wild-type PSD-95 in-
creased surface GluR1 levels by 63% and by 49%,
compared to untransfected neurons (Figures 1B and 1D).
The S295A-PSD-95 mutant, however, failed to enhance
surface GluR1 immunoreactivity significantly (104.3% ±
11.4%; Figures 1B and 1D). Similarly, the intensity of bas-
soon immunostaining was significantly increased on
neurons overexpressing S295D- or wild-type PSD-95,
but not S295A-PSD-95 (Figures 1C and 1D). Thus, a single
phosphorylatable residue (ser-295) influences synaptic
abundance of PSD-95 and the ability of PSD-95 to recruit
surface AMPA receptors and induce presynaptic accumu-
lation of bassoon.
Ser-295 Phosphorylation of PSD-95 Influences
Synaptic Potentiation
We next compared the effect of overexpression of wild-
type PSD-95, S295D-PSD-95, and S295A-PSD-95 on
excitatory synaptic transmission inCA1pyramidal neuronsNein hippocampal slice cultures (Figure 2). Simultaneous
recording of EPSCs was performed from neighboring
untransfected CA1 neurons and transfected CA1 pyrami-
dal neurons that were identified by cotransfected GFP.
Wild-type PSD-95 strongly enhanced AMPA-EPSCs
(5.77 ± 0.89-fold relative to untransfected cells), as previ-
ously reported (Ehrlich and Malinow, 2004; Futai et al.,
2007; Nakagawa et al., 2004; Schnell et al., 2002; Stein
et al., 2003). Overexpression of the phosphomimicking
mutant S295D-PSD-95 also caused a large increase in
AMPA-EPSC (7.59 ± 1.51-fold), but the nonphosphorylat-
able S295A-PSD-95 was significantly less potentiating
than wild-type (3.18 ± 0.57-fold) (Figures 2C and 2D).
Overexpression of wild-type PSD-95 also significantly
enhanced NMDA-EPSCs (1.88 ± 0.26-fold), similar to
S295D-PSD-95 (1.80 ± 0.27) (Figures 2A, 2B, and 2D),
though these effects were much smaller in degree than
those on AMPA-EPSCs. NMDA-EPSCs were not signifi-
cantly changed by S295A-PSD-95 (Figures 2C and 2D).
Futai et al. also found a significant enhancement of
NMDA-EPSC by PSD-95 overexpression (Futai et al.,
2007).
Phosphorylation of PSD-95 Ser-295 Regulated
by Activity and by JNK
To study ser-295 phosphorylation of PSD-95 more di-
rectly, we generated phosphospecific antibodies (named
‘‘pS-295’’) against a phosphopeptide corresponding to
this site [CSPRRY(pS)PVAKD]. On dot blots, the affinity-
purified pS-295 antibody recognized the phosphopeptide
[CSPRRY(pS)PVAKD] with good sensitivity, but showed
no reactivity against the equivalent nonphosphorylated
peptide (CSPRRYSPVAKD) (Figure S2A).
In immunoblots of hippocampal neuron cultures (DIV25–
28), the pS-295 antibody recognized a major band of 95
kDa (Figure S2B), consistent with a basal level of phos-
phorylation of PSD-95 on ser-295. Treatment of the neu-
ron cultures with okadaic acid, an inhibitor of protein
phosphatases PP1 and PP2A (100 nM, 2 hr) increased
the intensity of this pS-295 band. Treatment of the mem-
brane with calf intestine alkaline phosphatase abolished
the pS-295 signal, without affecting the bands detected
by antibody against total PSD-95 (Figure S2B). pS-295
antibody recognized a strong set of bands in COS-7 cells
transfected with wild-type PSD-95, but not S295A-PSD-
95 (Figure S2C). These data demonstrate that the pS-
295 antibody specifically recognizes PSD-95 phosphory-
lated on ser-295 and that phosphorylation of ser-295 of
PSD-95 occurs endogenously in neurons.
Which protein kinases might be responsible for the ser-
295 phosphorylation of PSD-95 in neurons? We tested
whether endogenous PSD-95 ser-295 phosphorylation
could be altered by specific inhibitors of protein kinases
in hippocampal neurons. Cultured hippocampal neurons
(DIV24–28) were treated with KT5718 (5 mM, PKA inhibi-
tor), KN-93 (10 mM, CaMKII inhibitor), PD98059 (25 mM,
ERK pathway inhibitor), SB203580 (2.5 mM, p38 inhibitor),
SP600125 (20 mM, JNK inhibitor), roscovitine (10 mM,uron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 489
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PSD-95 Phosphorylation by Rac-JNKFigure 1. Effects of PSD-95 Ser-295 Mutants on Synaptic Localization, Surface GluR1, and Bassoon
(A) Localization of myc-tagged S295D-PSD-95, wild-type PSD-95, or S295A-PSD-95 in hippocampal neurons. Cultured hippocampal neurons were
transfected at DIV14, and three days later were stained for myc. Bar graph showsmean ± SEM of number of myc puncta per 10 mmof dendrite. n = 16,
16, and 17 neurons from left to right. *p < 0.05, compared with WT-PSD-95.
(B) Effect of overexpression of S295D-PSD-95, wild-type PSD-95, or S295A-PSD-95 on surface GluR1 levels. Cultured hippocampal neurons were
transfected at DIV14–15 and stained 3–4 days later for surface GluR1 (green) and PSD-95 (red). Individual channels are shown in grayscale.
(C) Effect of overexpression of S295D-PSD-95, wild-type PSD-95, or S295A-PSD-95 (red) on immunostaining of bassoon (green) on transfected
neurons.
(D) Quantification of data from (B) and (C). Bar graph shows mean ± SEM of surface GluR1 and bassoon intensity, normalized to untransfected
neurons. n = 15–20 neurons for each. *p < 0.05; **p < 0.01 compared with untransfected neurons or neurons transfected with S295A-PSD-95.
(E) Diagram of PSD-95, showing location of ser-295.CDK5 inhibitor), or calphostin C (2 mM, PKC inhibitor) for
16 hr. Among these drugs, only the JNK inhibitor—
SP600125—strongly reduced phospho-ser-295 levels rel-
ative to DMSO control (Figure 3A). The other MAP kinase
pathway inhibitors (PD98059 and SB203580) at concen-
trations that block ERK and p38-signaling in neurons (Ehr-
lich and Malinow, 2004; Zhu et al., 2002) had little effect.
KN-93 actually increased the pS-295 band. None of the
pharmacological treatments for 16 hr altered the total
level of PSD-95 in cultured neurons (Figure 3A). A shorter
2 ht treatment with JNK inhibitor SP600125 also reduced
phospho-S295 PSD-95 levels, whereas 2 hr treatment
with other kinase inhibitors, including KN93, had no effect490 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc(Figure S3). These results suggest that JNK kinase activity
is involved, directly or indirectly, in the phosphorylation of
PSD-95 ser-295 in neurons.
Treatment of cultured hippocampal neurons (DIV25–28)
with tetrodotoxin (TTX, 2 mM, 16 hr) increased phosphory-
lation of ser-295 (Figure 3A). In contrast, bicuculline (25 mM,
16 hr) suppressed ser-295 phosphorylation relative to
DMSO control (Figure 3A). Similarly, in cultured hippo-
campal slices, phospho-ser-295 PSD-95 levels increased
with TTX and decreasedwith bicuculline (Figure 3B). Thus,
chronic changes in activity bidirectionally modulate ser-
295 phosphorylation of PSD-95. We noted that the total
PSD-95 band on western showed a subtle upward.
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PSD-95 Phosphorylation by Rac-JNKFigure 2. Effect of Ser-295 Mutants of PSD-95 on Synaptic Transmission in Cultured Hippocampal Slices
(A–C) (Top) Sample EPSC tracesmediated by AMPA-R (downward) and NMDA-R (upward) from pairs of transfected (Trans) and neighboring untrans-
fected (Untrans) cells. Stimulus artifacts were truncated. EPSC amplitudes (AMPA-R-EPSCs [middle] and NMDA-R-EPSCs [bottom]) were plotted for
each pair of transfected and neighboring untransfected cells. Each open symbol represents a single pair of recordings. Mean ± SEM are shown by
filled circles. (A) S295D-PSD-95 mutant. (B) Wild-type PSD-95. (C) S295A-PSD-95 mutant. PSD-95 and its variants enhanced AMPAR-EPSC ampli-
tudes (p < 0.00001). In contrast, there were slight increases in the NMDAR-EPSC amplitude by the overexpression of PSD-95 (p = 0.002) and S295D-
PSD-95 mutant (p = 0.093), but not S295A-PSD-95 mutant (p = 0.623).
(D) Summary of PSD-95 ser-295mutant overexpression on AMPA-R-EPSCs (top) and NMDA-R-EPSCs (bottom). Each Bar graph represents average
of ratios obtained from multiple pairs of transfected and untransfected neighboring neurons. Numbers of cell pairs were S295D (AMPA-R-EPSCs/
NMDA-R-EPSCs: 11/9); wild-type (30/41); S295A (12/10). *p < 0.05, compared with neurons transfected with S295A-PSD-95.mobility shift in cultures treated with TTX and KN-93, cor-
relating with the increased phosphorylation on ser-295
(Figures 3A and 3B).
Even short-term exposure to bicuculline (25 mM; 5–20
min) reduced PSD-95 phospho-ser-295 levels in neurons,
again without affecting total PSD-95 (Figure 3C). Treat-
ment with TTX elevated PSD-95 phospho-ser-295 levels
within tens of minutes, without affecting total PSD-95
(Figure 3C). These data indicate that ser-295 phosphoryla-
tion can be regulated rather quickly by synaptic activity.
Okadaic acid (100 nM, 2 hr) and calyculin A (20 nM, 2 hr),
which act as inhibitors of protein phosphatases PP1 and
PP2A, increased phosphorylation of ser-295; the PP2B in-
hibitor ascomycin (2–5 mM, 2 hr) had no effect (Figure 3D).
Thus, PP1 and/or PP2A might be responsible for dephos-
phorylation of PSD-95 ser-295 in neurons.
Given that a JNK inhibitor suppressed phosphorylation
of ser-295 in neurons, we next tested whether JNK can
phosphorylate PSD-95 in vitro on this site. A purified bac-
terial hexahistidine-tagged fusion protein of approxi-
mately the N-terminal half of PSD-95 (amino acids 41–
355) was used as substrate for in vitro kinase assays.
The PSD-95 fusion protein was readily phosphorylated
by activated recombinant human JNK1 (Upstate Biotech)
on ser-295, as assayed by immunoblotting with pS-295
antibody (Figure 3E). Note that ser-295 phosphorylation
is associatedwith a small upwardmobility shift in the PSD-Ne95 band on immunoblots (Figure 3E, asterisk). Moreover,
JNK1 overexpression in COS-7 cells increased phosphor-
ylation of cotransfected PSD-95 on ser-295, implying that
JNK1 can phosphorylate PSD-95 on ser-295 in a cellular
context as well as in vitro (Figure 3F).
Postsynaptic Levels of PSD-95 and Phospho-Ser-
295 Regulated by Activity and JNK
Our transfection experiments with ser-295 mutants of
PSD-95 suggested that phosphorylation of this residue fa-
vors the postsynaptic accumulation of PSD-95 (Figure 1).
If true, then the pool of PSD-95 that is phosphorylated on
ser-295 should be more enriched in the PSD than total
PSD-95. Indeed, compared with total PSD-95, the ser-
295 phosphorylated form of PSD-95 was more highly
enriched in PSD fractions of adult rat brain (Figure 4A;
compare synaptosome versus PSDI and PSDII).
We used immunostaining with the pS-295 antibody to
determine whether endogenous PSD-95 that is phosphor-
ylated on ser-295 is specifically localized at synapses of
cultured hippocampal neurons. As expected, pS-295 im-
munoreactivity colocalizedwith total PSD-95 in a punctate
pattern along dendrites in basal conditions (Figure 4B;
DMSO). To test whether PSD-95 synaptic targeting corre-
lates with phosphorylation on ser-295, wemodulated syn-
aptic activity with TTX and bicuculline, which have oppo-
site effects on phospho-ser-295 levels (see Figures 3Auron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 491
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PSD-95 Phosphorylation by Rac-JNKFigure 3. Specificity of pS-295 Antibody, and Regulation of Phospho-Ser-295 PSD-95 Levels by JNK and by Activity
(A) Effects of pharmacological kinase inhibitors and neuronal activity modulators on phospho-ser-295 levels of PSD-95. Cultured hippocampal neu-
rons at DIV 25–28 were treated with DMSO, 2 mM TTX, 25 mM bicuculline, KT5718 (5 mM, PKA inhibitor), KN-93 (10 mM, CaMKII inhibitor), PD98059
(25 mM, ERK inhibitor), SB203580 (2.5 mM, p38 inhibitor), SP600125 (20 mM, JNK inhibitor), roscovitine (10 mM, CDK5 inhibitor), or calphostin C (2 mM,
PKC inhibitor) for16 hr, and then immunoblotted with pS-295 antibody. After stripping, the blot was reprobed with mouse PSD-95 antibody. Graph
shows pS-295 immunoblot intensity (divided by total PSD-95 intensity) normalized to DMSO control (mean ± SEM of five independent experiments).
Statistical analysis was performed by one-way ANOVA, followed by the Dunnett’s test. *p < 0.01; **p < 0.01 compared with DMSO control.
(B) Effect of bicuculline (25 mM) or TTX (2 mM) treatment for 16 hr on phospho-ser-295-PSD-95 levels in organotypic slice cultures of rat hippocam-
pus, measured by immunoblotting as in (A). Graph shows pS-295 level (divided by total PSD-95 level), normalized to DMSO control (n = 4). Statistical
analysis was performed by one-way ANOVA, followed by the Dunnett’s test. ***p < 0.001; **p < 0.01, compared to untreated control.
(C) Acute bidirectional modulation of phospho-ser-295-PSD-95 levels by bicuculline and TTX. Cultured hippocampal neurons (DIV25–28) were
treated with bicuculline (25 mM) or TTX (2 mM) for the indicated time (min), and immunoblotted as in (A). Graphs show time course of pS-295 levels
(divided by total PSD-95 level), normalized to untreated cells (n = 3). Statistical analysis was performed by one-way ANOVA, followed by the Dunnett’s
test. *p < 0.05; **p < 0.01, compared to untreated control.
(D) Effect of phosphatase inhibitors on phospho-ser-295 levels. Cultured hippocampal neurons at DIV25–28 were treated with DMSO, 2 mM asco-
mycin (PP2B inhibitor), 20 nM calyculin A (PP1/PP2A inhibitor), or 100 nM okadaic acid (PP1/PP2A inhibitor) for 2 hr and immunoblotted as in (A).
Graph shows pS-295 levels (divided by total PSD-95 level) (n = 3), normalized to untreated control. Statistical analysis was performed by one-way
ANOVA, followed by the Dunnett’s test. **p < 0.01, compared to DMSO control.
(E) In vitro phosphorylation of PSD-95 on ser-295 by recombinant JNK1. Purified hexahistidine-tagged fusion protein of PSD-95 (amino acids 41–355)
was mixed with recombinant active JNK1 (see Experimental Procedures). After in vitro kinase reaction, protein samples were immunoblotted using
pS-295 antibody, mouse PSD-95, andmouse JNK1 antibody, as indicated. Asteriskmarks amobility shift of His-tagged PSD-95 fusion protein after in
vitro JNK1 kinase reaction.
(F) Phosphorylation of PSD-95 on ser-295 by JNK1 in COS-7 cells. Wild-type PSD-95 was transfected with vector control (pGW1-Myc) or JNK1. 30 hr
later, transfected COS-7 cell lysates were immunoblotted with rabbit pS-295 antibody or rabbit pJNK antibody. After stripping, the blot was reprobed
with mouse PSD-95 antibody or mouse myc antibody (9E10).and 3B). Corroborating the biochemical result, TTX (2 mM,
16 hr) robustly increased the brightness of dendritic pS-
295 puncta; pS-295 immunostaining intensity per area of
dendrite increased by >2-fold, compared toDMSOcontrol
(Figure 4B). Total PSD-95 staining intensity was also in-
creased, but to a lesser degree (40%). Since total level
of PSD-95 in neuronal culture lysates was unchanged by
western blotting during the same period of drug treatment492 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc(Figure 3A), the immunocytochemical result suggests a
higher enrichment of PSD-95 at synapses associated
with ser-295 phosphorylation. Conversely, bicuculline
(25 mM, 16 hr) strongly reduced pS-295 immunostaining
intensity to 25% of DMSO control, while total dendritic
PSD-95 staining intensity fell to55% (Figure 4B). In addi-
tion to confirming the bidirectional regulation of phospho-
ser-295 by activity, these immunocytochemical data.
Neuron
PSD-95 Phosphorylation by Rac-JNKFigure 4. PSD-95 Ser-295 Phosphoryla-
tion Is Bidirectionally Modulated by Neu-
ronal Activity and Depends on JNK
(A) Phospho-ser-295-PSD-95 is more enriched
in postsynaptic density than total PSD-95.
Subcellular and PSD fractions of rat forebrain
were immunoblotted with pS-295 or PSD-95
antibody. Amount of protein loaded is indi-
cated above each lane.
(B) Cultured hippocampal neurons (DIV24) were
treated with either DMSO, 25 mM bicuculline,
2 mM TTX, 2 mM TTX plus PD98059 (25 mM),
2 mM TTX plus SP100126 (20 mM), or 2 mM
TTX plus SB203580 (2.5 mM) for 16 hr before
cold methanol fixation and double immunos-
taining with pS-295 (green) and PSD-95 (red)
antibody. Individual channels are shown in
grayscale. Quantified fluorescence intensity
data are shown in the bar graph below. n =
20–25 microscope fields for each. ***p < 0.001,
compared with DMSO control.
(C) Cultured hippocampal neurons (DIV24)
were treated with either DMSO, 40 mM bicu-
culline, 2 mM TTX, 2 mM TTX plus PD98059
(25 mM), 2 mM TTX plus SP600125 (20 mM), or
2 mM TTX plus SB203580 (2.5 mM) for 16 hr.
Whole-cell lysates were immunoblotted with
pS-295 or PSD-95 antibody. Bar graph shows
pS-295 band intensity (divided by total PSD-95
in same lane) normalized to DMSO control
(n = 4, **p < 0.01).demonstrate that phospho-ser-295 levels correlate with
the abundance of total PSD-95 in synapses. As a more
subtle point, the larger amplitude fluctuation in pS-295
level versus total PSD-95 level implies that not all of synap-
tic PSD-95 is phosphorylated on ser-295 (i.e., nonphos-
phorylated PSD-95 is also present at synapses).
The TTX-induced increase of phospho-ser-295 and to-
tal PSD-95 immunostaining in dendrites was blocked by
JNK inhibitor SP600125 (20 mM) but not by p38 inhibitor
(SB203580, 2.5 mM) or ERK pathway inhibitor (PD98059,
25 mM) (Figure 4B). This result was backed up by immuno-
blot analysis, which showed that the TTX-induced in-
crease of phospho-ser-295 PSD-95 is prevented by
SP600125, but not by PD98059 (Figure 4C). Thus, JNK ki-
nase activity is involved in regulation of ser-295 phosphor-
ylation of endogenous PSD-95 at synapses.
Knockdown of JNK1 Reduces Ser-295
Phosphorylation and Postsynaptic PSD-95 Levels
Which JNK isoform is important for ser-295 phosphoryla-
tion in neurons? JNK1 and JNK3 are the major isoforms ofNJNK in neurons (Brecht et al., 2005; Coffey et al., 2002).
Transfection of a plasmid (JNK1-RNAi) that expresses
a small hairpin RNA against JNK1 suppressed expression
of endogenous JNK1, as measured by immunostaining
with a JNK1 antibody (Figure 5A; arrows). JNK1 immuno-
reactivity in neurons was unaffected by JNK3-RNAi or the
parent pSUPER vector (Figure 5A). In COS-7 cells, JNK1-
RNAi reduced expression of cotransfected JNK1, but not
JNK3 (Figure 5B). We tried to test the efficacy of JNK3-
RNAi in neurons, but failed for technical reasons because
two different JNK3 antibodies did not work in immunos-
taining of neurons. However, wewere able to demonstrate
the specific efficacy of JNK3-RNAi in COS-7 cells, where
protein expression of rat JNK3 was inhibited by cotrans-
fection of JNK3-RNAi but not JNK1-RNAi (Figure 5B).
We transfected JNK-RNAi constructs with b-gal marker
into cultured hippocampal neurons at DIV14–15, and ex-
pressed for 3 days. Knockdown of endogenous JNK1
strongly reduced ser-295 phosphorylation of PSD-95 (to
<20% of control), as assayed by pS-295 immunostaining
intensity in transfected neurons (Figure 5C, quantified ineuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 493
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PSD-95 Phosphorylation by Rac-JNKFigure 5. RNAi Knockdown of Endogenous JNK1 Inhibits Ser-295 Phosphorylation and Reduces Synaptic PSD-95 Levels
(A) Knockdown of endogenous JNK1with JNK1-RNAi. Cultured hippocampal neurons at DIV14–15 were cotransfected with pSUPER, JNK1-RNAi, or
JNK3-RNAi constructs plus b-gal marker (4:1 DNA ratio in favor of RNAi plasmid). Three days later, neurons were fixed and double stained with rabbit
b-gal and mouse JNK1 antibody. Arrows point to soma of transfected neurons.
(B) Efficacy and specificity of JNK1 and JNK3-RNAi in COS-7 cells. COS-7 cells were cotransfected with indicated expression vectors, and immu-
noblotted 60 hr later for JNK1 (Myc), JNK3 (HA), and tubulin.
(C) Knockdown of endogenous JNK1 causes loss of phospho-ser-295 staining. Cultured hippocampal neurons at DIV14–15 were cotransfected with
pSUPER, JNK1-RNAi, or JNK3-RNAi plus b-gal marker (4:1 ratio). Three days later, transfected neurons were double stained for b-gal (red) and phos-
pho-ser-295 (green). Individual channels are shown in grayscale. N.B. In the JNKi-RNAi panel, pS-295 staining is mostly from untransfected dendrites
crossing the field.
(D) Knockdown of endogenous JNK1 causes loss of postsynaptic PSD-95. Cultured hippocampal neurons at DIV14–15 were cotransfected with
pSUPER, JNK1-RNAi, or JNK3-RNAi, plus b-gal. Three days later, transfected neurons were double labeled for b-gal and total PSD-95. Only sin-
gle-channel images are shown.
(E) Quantitation of data from (C) and (D). Bar graph shows mean ± SEM of dendritic staining intensity of pS-295 and PSD-95, normalized to untrans-
fected cells. n = 14–18 neurons for each. ***p < 0.001 compared with pSUPER or JNK3-RNAi.
(F) Knockdown of endogenous JNK1 causes loss of surface GluR1. Cultured hippocampal neurons at DIV14–15 were cotransfected with pSUPER,
JNK1-RNAi, or JNK3-RNAi plus b-gal (4:1 ratio). Three days later, transfected neurons were double stained for b-gal and surface GluR1. Bar graph
shows mean ± SEM of dendritic surface GluR1 intensity, normalized to untransfected cells. n = 15–20 neurons for each. ***p < 0.001 compared with
pSUPER or JNK3-RNAi transfected neurons.5E). Intensity of total dendritic PSD-95 staining was also
significantly reduced, though to a lesser degree (50%;
Figures 5D and 5E). Neither total nor phospho-ser-295
PSD-95 was affected by control pSUPER or JNK3-RNAi
transfection (Figures 5C–5E). These results suggest that
JNK1, but probably not JNK3, is critically involved in phos-
phorylation of ser-295 of PSD-95 and in synaptic accumu-
lation of PSD-95. In addition, surface GluR1 levels were
reduced 50% in neurons transfected with JNK1-RNAi
but were unaffected by JNK3-RNAi or pSUPER alone494 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc(Figure 5F). An additional JNK1-RNAi construct (JNK1-
RNAi #2) targeting a different sequence in JNK1 mRNA
had similar effects on dendritic PSD-95 levels and surface
GluR1 expression (data not shown).
Knockdown of JNK1 Suppresses Basal Synaptic
Transmission
We compared the effect of JNK1 RNAi and JNK3 RNAi on
excitatory synaptic transmission inCA1pyramidal neurons
in hippocampal slice cultures (Figure S4). Knockdown of.
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PSD-95 Phosphorylation by Rac-JNKJNK1 suppressed AMPA-EPSCs (0.44 ± 0.06-fold relative
to untransfected). JNK1-RNAi also inhibited NMDA-
EPSCs, though to a lesser extent (0.58±0.07) (FigureS4A).
JNK3-RNAi had no significant effect on AMPA- and
NMDA-EPSCs (Figure S4B). These data are consistent
with the idea that specifically JNK1 promotes the synaptic
abundance of PSD-95 by phosphorylating ser-295. How-
ever, becauseRNAi knockdown of PSD-95 in cultured hip-
pocampal slice reduces AMPA- but not NMDA-EPSCs
(Elias et al., 2006; Nakagawa et al., 2004; Schluter et al.,
2006), the inhibition of NMDA-EPSC by JNK1-RNAi is un-
likely due to loss of PSD-95 alone. Thus, endogenous
JNK1 activity is important for the maintenance of synaptic
function, but perhaps involving substrates in addition to
PSD-95.
Rac1 Activity Promotes Ser-295 Phosphorylation
Small GTPases of the Rho family, particularly Rac1 and
Cdc42, are important upstream regulators of JNK in
various cell types (Hall, 2005; Weston and Davis, 2002).
To determine whether a Rho family GTPase is involved
in JNK-dependent phosphorylation of PSD-95 ser-295 in
neurons, we expressed dominant-negative forms of Rac1
(Rac1-N17), Rac3 (Rac3-N17), Cdc42 (Cdc42-N17), RhoA
(RhoA-N19), or RhoB (RhoB-N19) for 2 days (transfection
at DIV15, fixation at DIV17). Among the constructs tested,
only overexpression of Rac1-N17 reduced dendritic
PSD-95 immunostaining (to 40%; similar to RNAi of
JNK1; Figure 6A). Rac1-N17 reduced dendritic pS-295 im-
munostaining by65%, whereas RhoA-N19 had no effect
(Figure 6B). Surprisingly, Rac3-N17, which is 92% identi-
cal to Rac1, had little effect on dendritic PSD-95 levels
(Figure 6A). These data demonstrate that PSD-95 phos-
phorylation on ser-295 depends on Rac1, consistent
with a Rac1-JNK1 signaling pathway leading to ser-295
phosphorylation.
A recently developed inhibitor of Rac1 (NSC23766) is
selective for Rac1 over Cdc42 and RhoA (Gao et al.,
2004). Cultured hippocampal neurons at DIV25 were
treated with bicuculline (25 mM), TTX (2 mM), or TTX (2
mM) plus Rac1-inhibitor (NSC23766, 100 mM) for 16 hr
and immunoblotted for phospho-ser-295-PSD-95 and
phospho-JNK (Figure 6C). The TTX-induced increase
of ser-295 phosphorylation was blocked by NSC23766
Rac1-inhibitor, without any concomitant effect on total
PSD-95 levels (Figure 6C), showing that Rac1 activity is
important for regulated ser-295 phosphorylation in neu-
rons. However, these results do not prove that TTX in-
creases ser-295 phosphorylation via stimulation of Rac1.
Chronic treatment (16 hr) with TTX or bicuculline had
no detectable effect on total JNK activation levels, as
judged by phospho-JNK immunoblotting (Figure 6C).
NSC23766 (100 mM) alone for 16 hr reduced phospho-
ser-295 PSD-95 levels and phospho-JNK levels by50%
(Figure S5), suggesting that Rac1 is a major activator of
JNK in neurons.
Finally, we turned to RNAi knockdown of endogenous
Rac1 in cultured hippocampal neurons. When cotrans-Nfected in COS-7 cells, the Rac1-RNAi construct reduced
Rac1 protein expression, but had no effect on the highly
homologous Rac3 protein (Figure 6D) or RhoA (data not
shown). Consistent with dominant-negative Rac1-N17
and pharmacological Rac1-inhibitor results, RNAi knock-
down of endogenous Rac1 caused loss of dendritic PSD-
95 staining, whereas control pSUPER or RhoA-RNAi
transfection had no effect (Figure 6E). Knockdown of
Rac1 also strongly reduced phospho-ser-295 staining in
cultured neurons (Figure S6). Together, these data indi-
cate that Rac1 is an important regulator of JNK in neurons
and required for ser-295 phosphorylation and synaptic
accumulation of PSD-95. The data are consistent with
a Rac1-JNK1 signaling pathway that controls ser-295
phosphorylation and hence PSD-95 content at postsyn-
aptic sites. However, it is also possible that the loss of
dendritic PSD-95 with dominant-negative Rac1-N17 is
secondary to disturbance of synapse growth or mainte-
nance, because Rac1 is also known to promote spine
morphogenesis via regulation of the actin cytoskeleton
(Nakayama et al., 2000; Tashiro et al., 2000). In our mature
dissociated culture preparation, the expression of domi-
nant-negative Rac1 (Rac1-N17) or Rac1-RNAi construct
for 3 days led to a small reduction in density of dendritic
protrusions and thinner longer spines (Figure S7).
Bidirectional Regulation of Ser-295
Phosphorylation in Chemical LTD
and Chemical LTP
Synaptic excitation induced by bicuculline reduces
ser-295 phosphorylation on a time scale of minutes (Fig-
ure 3C). Which glutamate receptor might mediate
suppression of ser-295 phosphorylation? In cultured hip-
pocampal neurons, the NMDA receptor blocker DL-APV
(100 mM; 45 min) significantly increased phospho-ser-
295-PSD-95 levels (Figure S8). The AMPA receptor antag-
onist NBQX (10 mM; 45 min) had no significant effect
(Figure S8). We conclude that NMDA receptor activation
plays a dominant role in suppressing ser-295 phosphory-
lation.
Bath application of NMDA for short time periods is
widely used to induce ‘‘chemical LTD’’ in cultured neurons
and brain slices (Lee et al., 1998). NMDA treatment (75 mM)
of cultured hippocampal neurons caused a profound fall in
phospho-ser-295-PSD-95 levels within 5 min (Figure 7A).
Thus, acute stimulation of NMDA receptors can rapidly
dephosphorylate PSD-95 on ser-295. We measured
Rac1 activity (by GST-PAK1-PBD [p21-binding domain]
pulldown assay) and PP1/PP2A activity (see Experimental
Procedures) in cultured neurons stimulated with NMDA.
We focused on PP1/PP2A activity because these phos-
phatases seem to regulate basal phosphorylation on
ser-295 (see Figure 3D). GTP-Rac1 levels did not change
significantly after NMDA stimulation (5–10 min) or APV
treatment (Figure 7B). Phospho-JNK levels also were un-
affected by short-term NMDA treatment (data not shown).
PP1/PP2A phosphatase activity, however, increased
significantly following the same NMDA stimulationeuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 495
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PSD-95 Phosphorylation by Rac-JNKFigure 6. Inhibition of Rac1 Reduces Ser-295 Phosphorylation and Synaptic PSD-95 Levels
(A) Effects of dominant-negative Rho family GTPases on dendritic PSD-95. Neurons were transfected at DIV15 with dominant-negative constructs of
specific Rho GTPases or b-gal, as indicated, and stained 2 days later for PSD-95. Bar graph shows mean ± SEM of dendritic PSD-95 staining inten-
sity, normalized to untransfected cells. n = 15–18 neurons for each. ***p < 0.001, compared with untransfected neurons or b-gal-transfected neurons.
(B) Expression of Rac1-N17 causes loss of phospho-ser-295 staining. Cultured hippocampal neurons at DIV15 were cotransfected with b-gal, b-gal
plus Rac1-N17, or b-gal marker plus RhoA-N19 (1:4 ratio). Two days later, transfected neurons were double stained for b-gal and phospho-ser-295.
Graph shows showmean ± SEM of dendritic pS-295 staining intensity, normalized to untransfected cells. n = 20 neurons for each. ***p < 0.001, com-
pared with untransfected neurons or neurons transfected with b-gal or bgal plus RhoA-N19.
(C) Effect of Rac1-inhibitor (NSC23766) on ser-295 phosphorylation and phospho-JNK levels. Cultured hippocampal neurons at DIV25 were
untreated or treated with bicuculline (25 mM), TTX (2 mM), or TTX plus Rac-inhibitor (NSC23766, 100 mM, Calbiochem) for 16 hr. Cell lysates
were immunoblotted with pS-295, PSD-95, or phospho-JNK antibody. Bar graph shows mean ± SEM of band intensities, normalized to untreated.
n = 4. **p < 0.01.
(D) Specificity and efficacy of Rac1-RNAi in COS-7 cells. COS-7 cells were transfected with expression vectors for myc-Rac1 or myc-Rac3, plus
pSUPER vector or Rac1-RNAi constructs, as indicated, and immunoblotted 60 hr later for myc and tubulin.
(E) Knockdown of endogenous Rac1 causes depletion of synaptic PSD-95. Cultured hippocampal neurons at DIV15–16 were cotransfected with
pSUPER, Rac1-RNAi, or RhoA-RNAi construct, plus b-gal marker (4:1 ratio). Three days later, transfected neurons were double stained for b-gal
and PSD-95. Bar graph shows mean ± SEM of dendritic PSD-95 intensity, normalized to untransfected. n = 28 neurons for each. ***p < 0.001.(Figure 7C), suggesting that increased PP1/PP2A activity
may be responsible for NMDA-induced dephosphoryla-
tion of ser-295.
We then investigated whether PSD-95 ser-295 phos-
phorylation is affected in a ‘‘chemical LTP’’ protocol (cul-
tured hippocampal neurons treated with forskolin/roli-
pram /0 Mg2+ [see Experimental Procedures]), which is
known to increase synaptic strength and drive AMPA
receptors to the surface (Oh et al., 2006; Otmakhov et al.,
2004). In contrast to the rapid dephosphorylation induced496 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier InbyNMDA treatment (chemical LTD), ser-295 phosphoryla-
tion was increased by the chemical LTP protocol, occur-
ring over 25–50 min (Figure 7D, 7E2, compare with 7A).
The time course of PSD-95 ser-295 phosphorylation was
somewhat delayed compared to the time course of
GluR1 ser-845 phosphorylation and activation of ERK1/2
(phospho-ERK), which were also induced following chem-
ical LTP (Figures 7D, 7E1, and 7E3). The chemical LTP
protocol raised phospho-JNK (Figures 7D and 7E4) and
GTP-Rac1 levels in the cultured neurons (Figure 7F),c.
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PSD-95 Phosphorylation by Rac-JNKFigure 7. Bidirectional Regulation of Phospho-Ser-295 Levels by NMDA Treatment and Chemical LTP Induction
(A) NMDA treatment induces rapid dephosphorylation of ser-295. Cultured hippocampal neurons at DIV 24–27were stimulated with NMDA (75 mM) for
indicated times. Levels of phospho-ser-295 of PSD-95 were analyzed by immunoblotting with pS-295 antibody. After stripping, the blot was reprobed
with mouse PSD-95 antibody. Graphs show time course of pS-295 band intensity (divided by total PSD-95) after NMDA stimulation (n = 4; normalized
to untreated control). **p < 0.01, compared to untreated control; one-way ANOVA, followed by the Dunnett’s test.
(B) Lack of effect of APV and NMDA treatment on Rac1-GTP levels. Cultured hippocampal neurons at DIV24–27 were untreated or treated with APV
(100 mM, 40 min) or NMDA (75 mM for indicated times). Levels of GTP-Rac1 were analyzed by GST-PAK1-PBD pulldown assay. A representative im-
munoblot from three independent experiments is shown.
(C) NMDA treatment increases PP1/PP2A phosphatase activity. Cultured hippocampal neurons at DIV 27 were untreated or stimulated with NMDA
(75 mM) for 10 min, and equal amounts of cell lysate protein were analyzed by the Malachite Green PP1/PP2A phosphatase assay (see Experimental
Procedures). PP1/PP2Aphosphatase activitywas normalized tountreatedcontrol. Bar graph showsmean±SEMof four sets of experiments. **p < 0.01.
(D) Representative immunoblots showing effects of chemical LTP induction onPSD-95 ser-295 phosphorylation,GluR1 ser-845 phosphorylation, phos-
pho-ERK, and phospho-JNK.Cultured hippocampal neurons at DIV24–28were treatedwith 50 mM forskolin and 0.1mM rolipram in ACSF lackingMgCl2
(see Experimental Procedures). After 10 min, neurons were replaced in regular ACSF and then immunoblotted at indicated time points, using indicated
antibodies.
(E1–E4)Timecourseof (E1)GluR1pS-845 levels (dividedby tubulin level;n=6), (E2) pS-295 levels (dividedby totalPSD-95 level;n=6), (E3) pERK (divided
by tubulin; n = 3), and (E4) pJNK (divided by tubulin; n = 4) after chemical LTP induction. Statistical analysiswasperformedby one-wayANOVA, followed
by the Dunnett’s test. **p < 0.01; *p < 0.05, compared to samples before treatment with 50 mM forskolin/0.1 mM rolipram/0 MgCl2.
(F) Effect of chemical LTP induction on Rac1-GTP levels. 45 min after chemical LTP induction as above, GTP-Rac1 was measured by GST-PAK1-PBD
pulldown assay. Graph shows mean ± SEM of Rac1-GTP levels, *p < 0.05, t test; n = 3.
(G) Effect of chemical LTP induction on PP1/PP2A phosphatase activity. Graph shows mean ± SEM of PP1/PP2A phosphatase activity, normalized to
sample before treatment with 50 mM forskolin/0.1 mM rolipram/0 MgCl2. n = 3, p > 0.05, t test.consistent with the idea that ser-295 phosphorylation is
upregulated by the Rac1-JNK pathway. In contrast to
chemical LTD (Figure 7C), total PP1/PP2A phosphatase
activity was unaffected by the chemical LTP protocol
(Figure 7G). In short, phosphorylation of PSD-95 ser-295
is rapidly and bidirectionally regulated in neurons: it is
induced by chemical LTP, associated with enhanced
Rac1 and JNK activity, and inhibited by chemical LTD,
associated with elevated PP1/PP2A phosphatase activity.NChronic treatment with bicuculline (25 mM,16 hr) led to
a significant reduction of GTP-Rac1 (Figure S9), suggest-
ing that bicuculline reduces phospho-ser-295 PSD-95
levels by inhibiting the Rac1-JNK pathway (see Figure 3).
TTX treatment (2 mM, 16 hr) showed a trend toward in-
creased Rac1-GTP levels, but this did not reach statistical
significance. No change in total PP1/PP2A activity was
observed after 16 hr treatment with TTX or bicuculline
(Figure S9).euron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 497
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PSD-95 Phosphorylation by Rac-JNKFigure 8. Overexpression of S295D PSD-95 Inhibits NMDA-Induced GluR2 Internalization
Cultured hippocampal neurons were transfected with GFP, WT-PSD-95-GFP, S295D-PSD-95-GFP, or S295A-PSD-95-GFP at DIV16. Three days
later (DIV19), surface GluR2 was live-labeled with GluR2-N Ab, washed, and then were left untreated or treated with 75 mM NMDA for 10 min at
37C. Internalized GluR2 receptors and remaining surface GluR2 receptors were visualized with Alexa-568 (red) and Alexa-647 (blue) secondary
antibody, respectively (see Experimental Procedures). Transfected neurons were identified with GFP-channel (green). Bar graph shows mean ±
SEM of integrated intensity of internalized GluR2 receptor. n = 11, 10, 9, 15, 13, 18, 9, and 17 from left to right. **p < 0.01, compared with neurons
transfected with GFP. There was no difference in the GluR2 internalization between S295A-PSD-95 and GFP-transfected neurons (p > 0.05).Overexpression of S295D-PSD-95 Mutant Blocks
AMPA Receptor Internalization and LTD
NMDA bath application is well known to stimulate AMPA
receptor internalization. We found that overexpression of
the phosphomimicking S295D-PSD-95 mutant in cultured
hippocampal neurons inhibited GluR2 internalization in-
duced by NMDA, whereas S295A-PSD-95 mutant had
no effect (Figure 8). Wild-type PSD-95 overexpression
showed a trend toward inhibiting NMDA-induced GluR2
internalization, but this did not reach statistical signifi-
cance. These results suggest that ser-295 dephosphory-
lation of PSD-95 plays a functional role in inducible
AMPA receptor internalization.
The inhibition of NMDA-induced AMPA receptor
internalization by S295D-PSD-95 raised the question of
whether this phosphomimicking mutant would inhibit
LTD. To address this issue, we overexpressed the PSD-
95 mutant constructs with GFP marker in CA1 neurons
of cultured hippocampal slices (as in Figure 2), and inves-498 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier Itigated LTD of Schaffer collateral-CA1 synapses in whole-
cell recording mode (Figure 9). Overexpression of S295D-
PSD-95 blocked induction of LTD (96% ± 7% of baseline,
n = 8), whereas overexpression of S295A-PSD-95 had no
effect (63% ± 5% of baseline, n = 8). There was no differ-
ence in the magnitude of LTD between control untrans-
fected cells and cells transfected with S295A-PSD-95. It
should be noted that the loss of LTD in S295D-expressing
neurons occurred despite an elevated basal synaptic
transmission (see Figure 2); therefore, it cannot be attrib-
uted to ‘‘occlusion’’ of LTD. These results suggest that
dephosphorylation of ser-295 of PSD-95 is critical for
LTD induction.
DISCUSSION
Regulation of PSD-95 by Ser-295 Phosphorylation
Altering the abundance of the PSD-95 scaffold at synap-
ses is a primary means to control PSD-95 function andnc.
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PSD-95 Phosphorylation by Rac-JNKsynaptic strength. Consistent with this idea, synaptic
activity leads to depalmitoylation of PSD-95, which is cor-
related with depletion of synaptic PSD-95 clusters, loss of
AMPA receptors, andweakening of synapses (El-Husseini
et al., 2002). Activity-induced ubiquitination of PSD-95 and
subsequent lossofPSD-95 fromsynapsesbyproteasomal
degradation is also implicated in synaptic depression (Col-
ledge et al., 2003). Our study reveals amechanism for con-
trolling synaptic abundance of PSD-95 based on phos-
phorylation and dephosphorylation of a specific residue
of PSD-95. Phosphorylation of ser-295 occurs in vivo,
and it enhances the ability of PSD-95 to accumulate in
the PSD, to recruit surface AMPA receptors, and to
strengthen synaptic transmission.
Phosphorylation of ser-295 of PSD-95 is bidirectionally
regulated—it is inhibited by bicuculline and chemical LTD
but enhanced by TTX and chemical LTP. Ser-295 phos-
phorylation correlates with increased accumulation of
phosphorylated and total PSD-95 at synapses, which
would be expected to promote synaptic strength. The rel-
ative importance of ser-295 phosphorylation versus N-ter-
minal palmitoylation is unknown with respect to synaptic
localization of PSD-95. It is possible that ser-295 phos-
phorylation influences palmitoylation or vice versa, but
this is somewhat difficult to envisage since the N-terminal
cysteines and ser-295 are widely separated, at least in
primary structure.
Previous reports indicated that the effect of PSD-95
overexpression on synaptic function is not activity depen-
dent (i.e., occurs in the presence of highMg2+) (Ehrlich and
Malinow, 2004), which seems to be in superficial conflict
with our findings. However, ser-295 phosphorylation is
Figure 9. Overexpression of S295D-PSD-95 Blocks LTD in
CA1 Neurons of Organotypic Hippocampal Slice Cultures
CA1 neurons were biolistically transfected with S295D-PSD-95 or
S295A-PSD-95 (cotransfected with GFP) and recorded in whole-cell
patch-clamp mode. Induction of LTD was blocked in cells overex-
pressing S295D-PSD-95 (p > 0.05, comparison between 5 min and
40 min, n = 8). LTD was intact in S295A-PSD-95-transfected CA1 neu-
rons from organotypic hippocampal culture (p < 0.01, comparison be-
tween 5 min and 40 min, n = 8). There was no difference in the magni-
tude of LTD between S295A-PSD-95-transfected and nontransfected
control neurons (p > 0.05).Nenot absolutely required for synaptic potentiation, as indi-
cated by the 3-fold enhancement of AMPA-EPSCs by
S295A-PSD-95 overexpression. Ser-295 phosphorylation
also seems not absolutely necessary for PSD-95 to reach
the synapse, since (1) S295A-PSD-95 is present in spines
(albeit less concentrated thanwild-type or S295Dmutant);
(2) total PSD-95 levels at synapses fluctuate with activity
at a smaller amplitude than phospho-ser-295-PSD-95,
implying that ser-295-phosphorylated PSD-95 is only a
subset of synaptic PSD-95; (3) S295A-PSD-95 does not
act as a dominant-negative mutant in AMPA-EPSC poten-
tiation. The simplest explanation is that phosphorylation of
PSD-95 at ser-295 enhances PSD-95 stability, and hence
accumulation, at synapses, but phosphorylation itself is
not essential for targeting to synapses. Especially upon
overexpression (when it is unlikely to be stoichiometrically
regulated by activity-dependent phosphorylation), PSD-
95would be expected to potentiate synaptic transmission
whether or not activity is inhibited.
Ser-295-phosphorylated PSD-95 is more enriched in
PSD fractions than total PSD-95, and S295D-PSD-95
had a more potent effect on surface GluR1 levels and
AMPA EPSCs. These data argue that S295D-PSD-95 is
more synaptically enriched. An unanswered question is:
how does phosphorylation of ser-295 promote synaptic
accumulation of PSD-95? We do not believe that ser-
295 regulates degradation of PSD-95, because the degree
of ser-295 phosphorylation can change drastically with lit-
tle effect on total PSD-95 protein levels. Broadly speaking,
ser-295 phosphorylation could either facilitate the delivery
of PSD-95 to the synapse (e.g., by being engaged inmotor
trafficking), or it could increase the stability of PSD-95 at
the synapse (for instance, by strengthening PSD-95 inter-
actions with other PSD proteins).
Ser-295 resides in a ‘‘linker’’ of 67 amino acids between
PDZ domains 2 and 3, where it seems unlikely to influence
the binding interactions mediated by the PDZ or other
well-characterized domains of PSD-95. It is possible that
phosphorylation of ser-295 alters local protein conforma-
tion such that a yet-to-be identified protein-protein inter-
action is enhanced, thereby stabilizing PSD-95 in the
PSD. Whatever the underlying molecular mechanism, it
is interesting that PSD-93, a close relative of PSD-95,
also possesses a similar phosphorylation motif in the
PDZ2-PDZ3 linker region (Jaffe et al., 2004; Trinidad
et al., 2006). Other phosphorylation sites have been iden-
tified in PSD-95 that are phosphorylated by CDK5 and
CaMKII (Gardoni et al., 2006; Morabito et al., 2004), but
their significance is not clear.
Signal Transduction Pathway Underlying
Regulated PSD-95 Ser-295 Phosphorylation
Our data point to the Rac1-JNK1 pathway as being the
main mediator of ser-295 phosphorylation. The dephos-
phorylation of PSD-95 ser-295 seems to involve the phos-
phatases PP1 and/or PP2A. Our findings indicate that
different stimuli utilize different signaling mechanisms to
regulate phospho-ser-295 PSD-95 levels in neurons.uron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 499
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PSD-95 Phosphorylation by Rac-JNKNMDA stimulation (chemical LTD) induced dephosphory-
lation of PSD-95 ser-295 within minutes, correlated with
elevated PP1/PP2A phosphatase activity but unaltered
Rac1 or total JNK activity. We note that PP1 activation
and recruitment to stimulated synapses is required for
LTD (Morishita et al., 2001; Mulkey et al., 1994), raising
the question of whether PSD-95 is a critical substrate of
PP1 in synaptic depression. In contrast, chemical LTP
stimulated phosphorylation on ser-295, associated with
elevated Rac1/JNK activity but no change in PP1/PP2A.
These results underscore the bidirectional regulation of
phospho-ser-295-PSD-95 levels in neurons, and the dif-
ferent ways it can be achieved via controlling the balance
of activities of the Rac1-JNK kinase pathway and PP1/
PP2A phosphatases.
Physiological Role of Ser-295 Phosphorylation
Ser-295 phosphorylation of PSD-95 is regulated acutely,
i.e., within 5 min of chemical LTD and within 50 min of
chemical LTP stimulation, as well as chronically, i.e., in
response to prolonged alterations in activity levels (16 hr
TTX or bicuculline). Since ser-295 phosphorylation pro-
motes PSD-95 localization in synapses, the rapid dephos-
phorylation of this site would favor the loss of PSD-95 from
synapses following LTD-inducing stimuli, which has been
observed previously (Colledge et al., 2003). We found that
overexpression of the S295D-PSD-95 mutant, which
mimics phosphorylation and cannot be ‘‘dephosphory-
lated,’’ blocks induction of LTD. The simplest interpreta-
tion of these data is that dephosphorylation of PSD-95
ser-295 is critical for LTD, presumably because this de-
phosphorylation is required for dispersal of PSD-95 from
synaptic sites and subsequent mobilization and internali-
zation of AMPA receptors. In support of this hypothesis,
overexpression of S295D-PSD-95, but not wild-type or
S295A mutant, inhibits NMDA-induced AMPA receptor
internalization. A caveat of these experiments is that the
PSD-95 mutants are overexpressed, so this interpreta-
tion should be further tested by a knockin of the ser-295
mutation in the genome. In addition, because the S295D
mutant accumulates more in the synapse, we cannot
exclude the possibility that LTD is blocked simply by a
higher postsynaptic content of PSD-95, rather than by
specific inability of S295D-PSD-95 to undergo dephos-
phorylation.
Chronic changes in the abundance of postsynaptic
PSD-95 regulated by ser-295 phosphorylation could con-
tribute to homeostatic plasticity (synaptic scaling) (Turri-
giano and Nelson, 2004). Like synaptic scaling, total
PSD-95 content of synapses is regulated by activity over
a time course of many hours, correlating with phospho-
ser-295 levels. Homeostatic synaptic scaling is at least
partly mediated by postsynaptic changes in glutamate re-
ceptor content (Turrigiano and Nelson, 2004). Accumula-
tion of PSD-95 through increased ser-295 phosphoryla-
tion could contribute to increased postsynaptic AMPA
receptors during chronic inactivity (TTX) conditions.500 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc.EXPERIMENTAL PROCEDURES
pS-295 PSD-95 Phosphoantibody
Phosphopeptide (incorporating a cysteine residue at the N terminus) of
sequence CSPRRY(pS)PVAKD conjugated to hemocyanin was used
to immunize New Zealand White rabbits (Covance). For affinity purifi-
cation of the pS-295 PSD-95 antibody, antiserum was passed through
a SulfoLink column (Pierce) coupled with the nonphosphorylated pep-
tide (CSPRRYSPVAKD). Pass-through fractions were subsequently
purified on a SulfoLink column coupled with the phosphorylated pep-
tide. After washing with Tris-buffered saline, bound antibody was
eluted with 0.1 M glycine (pH 2.7).
Chemical LTP Induction
Cultured hippocampal neurons were incubated for 20 min at room
temperature in ACSF (in mM): 125 NaCl, 2.5 KCl, 1 MgCl2, 2 CaCl2,
33 D-glucose, and 25 HEPES (pH 7.3), then treated with 50 mM forsko-
lin and 0.1 mM rolipram in ACSF lacking MgCl2. After 10 min of stimu-
lation, neurons were replaced in ACSF containing 1 mM MgCl2 and
lysed with 23 SDS sample buffer at indicated time points.
In Vitro Kinase Assay
His6-tagged fusion protein of PSD-95 (aa 41–355 of rat PSD-95) was
expressed in E. coli BL21(DE3) and purified with Ni2+-NTA-Agarose
(QIAGEN). Purified protein (50 ng in 25 ml of reaction volume) was incu-
bated at 30C for 20 min in kinase buffer containing 50 mM Tris-HCl,
pH 7.5, 0.1 mM EGTA, 0.1% 2-mecaptoethanol, 5 mM HEPES, pH
7.4, 10 mM magnesium acetate, 2 mM CaCl2, and 0.1 mM ATP, with
constitutive active recombinant JNK1 (100 ng; Upstate Biotechnol-
ogy). Phosphorylation at serine-295 of PSD-95was detected by immu-
noblotting with pS-295 antibody.
Total PP1/PP2A Phosphatase Activity Assay
Total PP1/PP2A activity was measured using a Malachite Green PP1/
PP2A Phosphatase Assay kit (Upstate Biotechnology), which is opti-
mized for PP1 and PP2A, but cannot distinguish between these two
enzymes. The assay is based on dephosphorylation of a phosphopep-
tide substrate (K-R-pT-I-R-R); the released phosphate binds to mala-
chite green, leading to increased absorbance at 650 nm. Cultured hip-
pocampal neurons were washed with ice-cold Tris-buffered saline,
scraped into phosphatase extraction buffer (20 mM imidazol-HCl,
2 mM EDTA, pH 7.0, with 10 mg/ml of aprotinin, leupeptin, 1 mM ben-
zamidine, and 1 mM PMSF) and then sonicated twice for 10 s. Result-
ing cell lysates (equal amounts of protein) were used for phosphatase
activity assay. Absorbance values at 650 nm were subtracted by that
of negative control (no cell lysate added).
Rac1 Activation Assay
The active (GTP-bound) form of Rac1 was detected using EZ-Detect
Rac1 Activation kit (Pierce, Rockford, IL), which is based on specific
pulldown of Rac1-GTP by GST-PAK1-PBD (p21-binding domain),
which contains the Rac1-GTP binding domain of Rac1 effector
PAK1. Hippocampal neurons were lysed with cold MLB (25 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP-40, 1 mM DTT,
and 5% glycerol). Equal amounts of protein from cleared cell lysates
were incubated with beads charged with GST-PAK1-PBD for 1 hr at
4C. Beads were washed with cold MLB three times. Bound proteins
were eluted by 23 SDS sample buffer, and immunoblotted for Rac1
using monoclonal antibody included in the assay kit (Pierce).
Image Acquisition and Quantification
Confocal images of neurons were obtained using a Zeiss 633 (NA 1.4)
objective with sequential acquisition settings at the maximal resolution
of the confocal (1024 3 1024 pixels). The confocal microscope
settings were kept the same for all scans when fluorescence intensity
was compared. All measurements were performed using ImageJ (NIH)
software. For the surface AMPA receptor and bassoon quantification,
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PSD-95 Phosphorylation by Rac-JNKoutlines of dendrites from transfected and untransfected cells were
carefully traced. Fluorescence intensity was then determined for the
traced areas. Staining intensity measurements are expressed in arbi-
trary units of fluorescence per square area. All values in figures and
text refer to mean ± SEM unless otherwise stated. N refers to number
of cells unless otherwise indicated. Statistical analysis of nonelectro-
physiological data was performed with Student’s t test.
Electrophysiology
Electrophysiological recordings were carried out in organotypic slice
cultures of rat hippocampus as described (Nakagawa et al., 2004).
Neurons were transfected using biolistic gene gun (BioRad) at DIV4–
6 {total 100 mg DNA; at a ratio of 9:1 (construct to test/marker
pEGFP-C1 [Clontech]) for the overexpression of PSD-95 and its vari-
ants, and at a ratio of 9:1 (RNAi construct to test/marker pEGFP-C1)
for the RNAi experiments}. Electrophysiological recordings were per-
formed 3 days (overexpression experiment) or 5 days (RNAi experi-
ment) after transfection. Recordings were carried out in solution
containing (mM): NaCl 119, KCl 2.5, CaCl2 4, MgCl2 4, NaHCO3 26,
NaH2PO4 1, glucose 11, picrotoxin 0.15, and 2-chloroadenosine 0.01,
gassed with 5% CO2/95% O2, at pH 7.4. Patch recording pipettes
(2–4 M ohms) were filled with internal solutions containing (in mM):
115 cesium methanesulfonate, 20 CsCl, 10 HEPES, 2. 5 MgCl2, 4
ATP disodium salt, 0.4 GTP trisodium salt, 10 sodium phosphocrea-
tine, and 0.6 EGTA, at pH 7.25. For basal synaptic transmission,
whole-cell recordings were made simultaneously from a pair of neigh-
boring CA1 pyramidal neurons, one transfected and the other untrans-
fected, while stimulating presynaptic fibers at 0.2 Hz. Synaptic AMPA
receptor responses were recorded at –60 mV and NMDA receptor re-
sponses at +40 mV in the presence of NBQX (0.01 mM). Experiments
were done blind to the DNA constructs used. Results are reported as
mean ± SEM. Statistical significance was evaluated by Mann-Whitney
test for EPSC amplitude, Kruskal-Wallis ANOVA for Figure 2D.
For LTD experiments, hippocampal slice cultures were prepared
from 7-day-old rats and cultured for 6–8 days in vitro. Neurons were
transfected at DIV3 (100 mg DNA; 90% of the construct to test; 10%
pEGFP-C1) and recorded 3–5 days after transfection. Stimulation
was delivered to Schaffer collateral-CA1 input every 15 s (0.033 Hz
each input). EPSC amplitude, series resistance, and input resistance
were monitored and analyzed on-line and off-line using the LTP pro-
gram (Anderson and Collingridge, 2001). Only cells with series resis-
tance <25 MU with a change in series resistance <10% from the start
were included in this study. Synaptic AMPA receptor responses were
recorded at 70 mV. Stimulation intensity was set between 5–15 V to
produce 50%–70% of maximal response. A stable baseline recording
for 10 min was required prior to any experimental manipulation. To in-
duce LTD, 1 Hz stimulation (200 stimuli) at40mVwas delivered. Dur-
ing 1 Hz stimulation, averages were made of 20 consecutive sweeps,
and the other input was not stimulated. Data pooled across experi-
ments are expressed as the mean ± SEM, and effects of conditioning
stimulation were measured between 20–25 min after induction of LTD.
Significance was tested using the Student’s two-tailed t test.
Additional experimental procedures are described in Supplemental
Data.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/56/3/488/DC1/.
ACKNOWLEDGMENTS
We thank Potus Aspenstrom for Rac1-N17, Rac3-N17, Cdc42-N17,
RhoA-N19, and RhoB-N19), and Michael Kracht for JNK3 expression
vectors. K.F. is a recipient of a Special Postdoctoral Researchers
Fellowship from RIKEN. This work was supported by NIH grants
(MH076936 to M.S.; DA017310 to Y.H.), BBSRC (K.C.). M.S. is Inves-
tigator of the Howard Hughes Medical Institute.NReceived: October 20, 2006
Revised: June 29, 2007
Accepted: September 11, 2007
Published: November 7, 2007
REFERENCES
Anderson, W.W., and Collingridge, G.L. (2001). The LTP Program:
a data acquisition program for on-line analysis of long-term potentia-
tion and other synaptic events. J. Neurosci. Methods 108, 71–83.
Beique, J.C., and Andrade, R. (2003). PSD-95 regulates synaptic
transmission and plasticity in rat cerebral cortex. J. Physiol. 546,
859–867.
Bingol, B., and Schuman, E.M. (2004). A proteasome-sensitive con-
nection between PSD-95 and GluR1 endocytosis. Neuropharmacol-
ogy 47, 755–763.
Brecht, S., Kirchhof, R., Chromik, A., Willesen, M., Nicolaus, T., Rai-
vich, G., Wessig, J., Waetzig, V., Goetz, M., Claussen, M., et al.
(2005). Specific pathophysiological functions of JNK isoforms in the
brain. Eur. J. Neurosci. 21, 363–377.
Cheng, D., Hoogenraad, C.C., Rush, J., Ramm, E., Schlager, M.A.,
Duong, D.M., Xu, P., Rukshan, S., Hanfelt, J., Nakagawa, T., et al.
(2006). Relative and absolute quantification of postsynaptic density
proteome isolated from rat forebrain and cerebellum. Mol. Cell. Pro-
teomics 5, 1158–1170.
Coffey, E.T., Smiciene, G., Hongisto, V., Cao, J., Brecht, S., Herdegen,
T., and Courtney, M.J. (2002). c-Jun N-terminal protein kinase (JNK) 2/
3 is specifically activated by stress, mediating c-Jun activation, in the
presence of constitutive JNK1 activity in cerebellar neurons. J. Neuro-
sci. 22, 4335–4345.
Colledge, M., Snyder, E.M., Crozier, R.A., Soderling, J.A., Jin, Y., Lan-
geberg, L.K., Lu, H., Bear, M.F., and Scott, J.D. (2003). Ubiquitination
regulates PSD-95 degradation and AMPA receptor surface expres-
sion. Neuron 40, 595–607.
Craven, S.E., El-Husseini, A.E., and Bredt, D.S. (1999). Synaptic tar-
geting of the postsynaptic density protein PSD-95 mediated by lipid
and protein motifs. Neuron 22, 497–509.
Ehrlich, I., and Malinow, R. (2004). Postsynaptic density 95 controls
AMPA receptor incorporation during long-term potentiation and expe-
rience-driven synaptic plasticity. J. Neurosci. 24, 916–927.
El-Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., and
Bredt, D.S. (2000). PSD-95 involvement in maturation of excitatory
synapses. Science 290, 1364–1368.
El-Husseini, A.D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q.,
Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R.A.,
and Bredt, D.S. (2002). Synaptic strength regulated by palmitate
cycling on PSD-95. Cell 108, 849–863.
Elias, G.M., Funke, L., Stein, V., Grant, S.G., Bredt, D.S., and Nicoll,
R.A. (2006). Synapse-specific and developmentally regulated target-
ing of AMPA receptors by a family of MAGUK scaffolding proteins.
Neuron 52, 307–320.
Futai, K., Kim, M.J., Hashikawa, T., Scheiffele, P., Sheng, M., and Hay-
ashi, Y. (2007). Retrograde modulation of presynaptic release proba-
bility through signaling mediated by PSD-95-neuroligin. Nat. Neurosci.
10, 186–195.
Gao, Y., Dickerson, J.B., Guo, F., Zheng, J., and Zheng, Y. (2004).
Rational design and characterization of a Rac GTPase-specific small
molecule inhibitor. Proc. Natl. Acad. Sci. USA 101, 7618–7623.
Gardoni, F., Polli, F., Cattabeni, F., and Di Luca, M. (2006). Calcium-
calmodulin-dependent protein kinase II phosphorylation modulates
PSD-95 binding to NMDA receptors. Eur. J. Neurosci. 24, 2694–2704.
Hall, A. (2005). Rho GTPases and the control of cell behaviour. Bio-
chem. Soc. Trans. 33, 891–895.euron 56, 488–502, November 8, 2007 ª2007 Elsevier Inc. 501
Neuron
PSD-95 Phosphorylation by Rac-JNKJaffe, H., Vinade, L., and Dosemeci, A. (2004). Identification of novel
phosphorylation sites on postsynaptic density proteins. Biochem. Bio-
phys. Res. Commun. 321, 210–218.
Kim, E., and Sheng, M. (2004). PDZ domain proteins of synapses. Nat.
Rev. Neurosci. 5, 771–781.
Lee, H.K., Kameyama, K., Huganir, R.L., and Bear, M.F. (1998). NMDA
induces long-term synaptic depression and dephosphorylation of the
GluR1 subunit of AMPA receptors in hippocampus. Neuron 21,
1151–1162.
Morabito, M.A., Sheng, M., and Tsai, L.H. (2004). Cyclin-dependent
kinase 5 phosphorylates the N-terminal domain of the postsynaptic
density protein PSD-95 in neurons. J. Neurosci. 24, 865–876.
Morishita, W., Connor, J.H., Xia, H., Quinlan, E.M., Shenolikar, S., and
Malenka, R.C. (2001). Regulation of synaptic strength by protein phos-
phatase 1. Neuron 32, 1133–1148.
Mulkey, R.M., Endo, S., Shenolikar, S., and Malenka, R.C. (1994). In-
volvement of a calcineurin/inhibitor-1 phosphatase cascade in hippo-
campal long-term depression. Nature 369, 486–488.
Nakagawa, T., Futai, K., Lashuel, H.A., Lo, I., Okamoto, K., Walz, T.,
Hayashi, Y., and Sheng, M. (2004). Quaternary structure, protein
dynamics, and synaptic function of SAP97 controlled by L27 domain
interactions. Neuron 44, 453–467.
Nakayama, A.Y., Harms, M.B., and Luo, L. (2000). Small GTPases Rac
and Rho in themaintenance of dendritic spines and branches in hippo-
campal pyramidal neurons. J. Neurosci. 20, 5329–5338.
Oh, M.C., Derkach, V.A., Guire, E.S., and Soderling, T.R. (2006). Extra-
synaptic membrane trafficking regulated by GluR1 serine 845 phos-
phorylation primes AMPA receptors for long-term potentiation. J.
Biol. Chem. 281, 752–758.502 Neuron 56, 488–502, November 8, 2007 ª2007 Elsevier IncOtmakhov, N., Khibnik, L., Otmakhova, N., Carpenter, S., Riahi, S., As-
rican, B., and Lisman, J. (2004). Forskolin-induced LTP in the CA1 hip-
pocampal region is NMDA receptor dependent. J. Neurophysiol. 91,
1955–1962.
Scannevin, R.H., and Huganir, R.L. (2000). Postsynaptic organization
and regulation of excitatory synapses. Nat. Rev. Neurosci. 1, 133–141.
Schluter, O.M., Xu, W., and Malenka, R.C. (2006). Alternative N-termi-
nal domains of PSD-95 and SAP97 govern activity-dependent regula-
tion of synaptic AMPA receptor function. Neuron 51, 99–111.
Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D.S., and
Nicoll, R.A. (2002). Direct interactions between PSD-95 and stargazin
control synaptic AMPA receptor number. Proc. Natl. Acad. Sci. USA
99, 13902–13907.
Stein, V., House, D.R., Bredt, D.S., and Nicoll, R.A. (2003). Postsynap-
tic density-95 mimics and occludes hippocampal long-term potentia-
tion and enhances long-term depression. J. Neurosci. 23, 5503–5506.
Tashiro, A., Minden, A., and Yuste, R. (2000). Regulation of dendritic
spine morphology by the rho family of small GTPases: antagonistic
roles of Rac and Rho. Cereb. Cortex 10, 927–938.
Trinidad, J.C., Specht, C.G., Thalhammer, A., Schoepfer, R., and Bur-
lingame, A.L. (2006). Comprehensive identification of phosphorylation
sites in postsynaptic density preparations. Mol. Cell. Proteomics 5,
914–922.
Turrigiano, G.G., and Nelson, S.B. (2004). Homeostatic plasticity in the
developing nervous system. Nat. Rev. Neurosci. 5, 97–107.
Weston, C.R., and Davis, R.J. (2002). The JNK signal transduction
pathway. Curr. Opin. Genet. Dev. 12, 14–21.
Zhu, J.J., Qin, Y., Zhao, M., Van Aelst, L., and Malinow, R. (2002). Ras
and Rap control AMPA receptor trafficking during synaptic plasticity.
Cell 110, 443–455..
